Skip to main content

EDITORIAL article

Front. Neurol., 26 November 2021
Sec. Movement Disorders
This article is part of the Research Topic Managing Parkinson's Disease with a Multidisciplinary Perspective View all 13 articles

Editorial: Managing Parkinson's Disease With a Multidisciplinary Perspective

  • 1Division of Neurology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada
  • 2Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
  • 3Movement Disorders Clinic, Clinical Neurodegenerative Research Unit, Mexico City, Mexico
  • 4Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Mexico
  • 5Department of Neurology, Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States

Parkinson's Disease (PD) is a complex and heterogeneous disorder from prodromal to advanced stages, with a wide range of motor and non-motor symptoms from bradykinesia and rigidity to dysautonomia, sleep disturbances, and cognitive impairment (1). Such a clinical diversity necessitates the involvement of healthcare professionals from different disciplines for an optimal management plan. Clinical guidelines recommend that all persons with PD should have access to a broad range of medical and allied health professionals for personalized, integrative, and multidisciplinary care (2, 3). This is supported by growing evidence showing the effects of integrated multidisciplinary interventions on improving quality of life and disease progression in people with PD (46).

Apart from symptomatic management and clinical care, other aspects of PD also warrant a multidisciplinary approach with a wide variety of expertise being involved from discovery of its pathophysiology and early prodromal stage to progression of parkinsonian features as medications' side effects. Roiter et al. analyzed the prevalence of parkinsonian symptoms in patients with severe mental illnesses admitted to a monocentric inpatient psychiatry ward. Parkinsonian (previously referred to as extrapyramidal) symptoms were quite common in this population (50.5%), with tremor (33%) being the most common manifestation. Only a minority of patients met the criteria for possible PD, which were significantly older, had more medical comorbidities with a larger number of medications including antipsychotics, and slightly more than half of them had reduced striatal dopamine transporter binding in 123I-FP-CIT SPECT. Whether antipsychotic medications unmask underlying neurodegenerative pathology by quickening the progression of the prodromal stage is not yet clear (7).

Gastrointestinal problems such as constipation are increasingly appreciated as another non-motor prodromal feature (1) and/or risk factor for developing PD (8), integrating another discipline into the diagnosis, and care of, people with PD. In their longitudinal study on de novo PD patients, Palacios et al. showed that Levodopa, as the mainstay of PD symptomatic therapy, did not change the gut microbiota composition after 3 months of initiation. Nevertheless, they observed a marginally lower abundance of Clostridium group IV in PD patients with a good response to Levodopa, which needs further investigation in the future.

Multidisciplinary diagnostic approaches such as neuroimaging techniques and other biomarkers are helpful to analyze overlapping movement disorders syndromes. There is evidence suggesting that patients diagnosed with essential tremor (ET) are at increased risk of developing PD (9). This relationship has been controversial as both disorders are common with significant clinical overlap between them. In this special article, Wang et al. reviewed the evidence on the application of neuroimaging [i.e., transcranial sonography (TCS), voxel-based morphometry, diffusion tensor imaging, proton MR spectroscopy], and potential multidisciplinary clinical biomarkers (i.e., non-motor symptoms and heart rate variability) suggestive of prodromal PD in ET. Current evidence suggests that patients with ET have an increased risk of developing PD, especially those with substantia nigra hyperechogenicity in TCS and in ET patients with specific tremor features, non-motor, genetic, and autonomic characteristics.

One very well-appreciated multidisciplinary aspect of PD is the caring and management practices beyond the routine protocols. There is an increasing interest in assessing the benefits of different physiotherapy and exercise interventions in patients with PD. Multiple mobility and rehabilitative strategies have been recognized as part of a multidisciplinary approach to PD management. As such the roles of allied health care members, namely physiotherapists and occupational therapists, in the multidisciplinary care of PD have been well-recognized (10). In a small, open-label, prospective study (Kotani et al.) aimed to investigate whether core exercise complemented with a hybrid assistive limb for lumbar support may improve the motor function in PD patients. The authors reported significant improvement in standard, validated motor measures at the end of the trial (after 3 months) with adequate safety. In a randomized controlled clinical trial, Segura et al. assessed the impact of a high-intensity tandem bicycle program on symptoms severity. They noted significant improvement in motor function clinically and in biochemical and functional neuroimaging variables. Giménez-Llort et al. proposed the “PasoDoble,” as a novel dance/music patient-caregiver intervention in PD patients. In this methods article, they reviewed the rationale on evidence-based therapeutic benefits of dance/music therapy and highlighted the potential benefit of this specific multidisciplinary technique.

Complementary medicine involves health care practices not considered as part of standard care that are used along with conventional medicine; when these practices are combined in a coordinated and standardized manner the result is integrative medicine (11). Huang et al. performed a systematic review on the effectiveness of acupuncture using the AMSTAR-2 and GRADE criteria. Overall, acupuncture was safe and improved some axial parkinsonian symptoms. However, the more striking finding was that most studies were rated as very low to low quality thus highlighting the need for better-designed studies in the future. Sharpe et al. reviewed non-pharmacological interventions in the context of axial and cognitive symptoms in early PD. The effect of balance, posture, speech, swallowing, and cognitive interventions proved to be of value highlighting the role of a unified multidisciplinary plan with an individualized approach.

Advanced management in PD, as another aspect of multidisciplinary care, is usually needed when oral or transdermal medications fall short in controlling the motor and non-motor fluctuations and accompanying complications such as dyskinesia with a large impact on quality of life and daily life activities (12). These advanced therapies include deep brain stimulation (DBS), continuous levodopa-carbidopa intestinal gel, and continuous subcutaneous apomorphine infusion. Qi et al. reported motor outcomes at 1 year in 40 individuals with PD who underwent subthalamic nucleus DBS. DBS improved motor function in all patients with various indexes of progression, yet the fast-progression group had less improvement. The slightly different outcome depending on the preoperative progression index might be a useful indicator for the multidisciplinary team involved in this type of management.

Aye et al. conducted a review with the objective of presenting current evidence and gaps in knowledge of multidisciplinary management and provision of community care of people with PD. The authors described their 14-year experience based on the Partners Community Care Program in Singapore that provides care for people with PD in the community and at their homes. The authors argued that although there is scarce experimental evidence supporting the use of multidisciplinary management, probably due to the great heterogeneity of the interventions and the need to individualize treatment, multidisciplinary management in PD should be recommended. Interdisciplinary or transdisciplinary support, as well as remote support with tools such as telemedicine, are feasible methods to provide and achieve the ideal patient-centric management. In their perspective article, Göttgens et al. discussed the impact of “sex” and “gender” in the multidisciplinary management of patients with PD. For motor symptoms such as imbalance and dyskinesias, authors propose possible sex- and gender-sensitive interventions such as balance training and DBS. Regarding non-motor symptoms, a reduction or discontinuation of dopaminergic therapies, cognitive behavioral therapy, referrals for training coping skills, and social support interventions were suggested. With respect to lifestyle, authors recommend self-monitoring of weight and dietetic plan for men and physical exercise and motivational interventions in women. Finally, in terms of social support, they suggest proactively identifying patients' social networks and referral to social support groups as well as regular evaluations to identify caregiver strain and improve their education about PD. It is crucial to identify these sex- and gender-related differences in knowledge and care provision to optimize the multidisciplinary management plan for people with PD.

Capitalizing on the importance of managing PD with a multidisciplinary approach, one must consider its potentially prohibitive cost by involving a broad range of medical and allied health professionals. One way to overcome its financial burden is innovative virtual or in-person platforms such as online health communities or patients' networks where professionals and patients can meet online in a secured environment to share their experiences (10).

Author Contributions

This editorial was written by S-MF, MR-V, DM-R, and AR-Z and edited by S-MF. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Fereshtehnejad SM, Yao C, Pelletier A, Montplaisir JY, Gagnon JF, Postuma RB. Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study. Brain. (2019) 142:2051–67. doi: 10.1093/brain/awz111

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Factor SA, Bennett A, Hohler AD, Wang D, Miyasaki JM. Quality improvement in neurology: Parkinson disease update quality measurement set: executive summary. Neurology. (2016) 86:2278–83. doi: 10.1212/WNL.0000000000002670

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Radder DLM, Nonnekes J, van Nimwegen M, Eggers C, Abbruzzese G, Alves G, et al. Recommendations for the organization of multidisciplinary clinical care teams in Parkinson's disease. J Parkinsons Dis. (2020) 10:1087–98. doi: 10.3233/JPD-202078

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Foster ER, Bedekar M, Tickle-Degnen L. Systematic review of the effectiveness of occupational therapy-related interventions for people with Parkinson's disease. Am J Occup Ther. (2014) 68:39–49. doi: 10.5014/ajot.2014.008706

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Fereshtehnejad SM, Lokk J. Active aging for individuals with Parkinson's disease: definitions, literature review, and models. Parkinsons Dis. (2014) 2014:739718. doi: 10.1155/2014/739718

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Lidstone SC, Bayley M, Lang AE. The evidence for multidisciplinary care in Parkinson's disease. Expert Rev Neurother. (2020) 20:539–49. doi: 10.1080/14737175.2020.1771184

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Fereshtehnejad SM, Dawson BK, Pelletier A, Montplaisir JY, Postuma RB. Long lag between drug-induced Parkinsonism and idiopathic Parkinson's disease in idiopathic REM sleep behavior disorder. Mov Disord Clin Pract. (2018) 5:203–5. doi: 10.1002/mdc3.12576

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. (2017) 18:509. doi: 10.1038/nrn.2017.91

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Tarakad A, Jankovic J. Essential tremor and Parkinson's disease: exploring the relationship. Tremor Other Hyperkinet Mov. (2018) 8:589. doi: 10.7916/D8MD0GVR

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Radder DLM, Sturkenboom IH, van Nimwegen M, Keus SH, Bloem BR, de Vries NM. Physical therapy and occupational therapy in Parkinson's disease. Int J Neurosci. (2017) 127:930–43. doi: 10.1080/00207454.2016.1275617

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Tabish SA. Complementary and alternative healthcare: is it evidence-based? Int J Health Sci. (2008) 2:5–9.

12. Hwang H, Norris SA. Managing advanced Parkinson disease. J Geriatr Psychiatry Neurol. (2021) 34:289–300. doi: 10.1177/08919887211018277

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: multidisciplinary approach, treatment, interdisciplinary teams, patient-centered care, management, Parkinson's Disease (PD)

Citation: Fereshtehnejad S-M, Rodríguez-Violante M, Martinez-Ramirez D and Ramirez-Zamora A (2021) Editorial: Managing Parkinson's Disease With a Multidisciplinary Perspective. Front. Neurol. 12:799017. doi: 10.3389/fneur.2021.799017

Received: 21 October 2021; Accepted: 01 November 2021;
Published: 26 November 2021.

Edited and reviewed by: Pedro J. Garcia-Ruiz, University Hospital Fundación Jiménez Díaz, Spain

Copyright © 2021 Fereshtehnejad, Rodríguez-Violante, Martinez-Ramirez and Ramirez-Zamora. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Seyed-Mohammad Fereshtehnejad, sm.fereshtehnejad@ki.se

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.